levodopa has been researched along with 2019 Novel Coronavirus Disease in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 13 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adamski, P; Anielska-Michalak, E; Bartuś, S; Brycht, O; Budaj, A; Curzytek, A; Drożdż, J; Dudek, A; Gąsior, M; Gromadziński, L; Gruchała, M; Grzelakowska, K; Grzelakowski, P; Jaguszewski, M; Jankowski, P; Kamiński, L; Kasprzak, M; Kaźmierczak, J; Kleinrok, A; Kostkiewicz, M; Koziński, M; Król, P; Kryś, J; Kubica, A; Kubica, J; Kulawik, T; Legutko, J; Lesiak, M; Leszek, P; Minczew, G; Mindykowski, M; Mitkowski, P; Navarese, EP; Nessler, J; Ostrowska, M; Pawlak, A; Podhajski, P; Prokopczuk, J; Skonieczny, G; Sobkowicz, B; Sowiński, S; Stankala, S; Stolarek, W; Szymański, P; Tomaszuk-Kazberuk, A; Tycińska, A; Wester, A; Wilczewski, P; Zdrojewski, T | 1 |
| Gultekin, M; Tufekcioglu, Z | 1 |
| Artusi, CA; Imbalzano, G; Ledda, C; Lopiano, L; Montanaro, E; Rizzone, MG; Romagnolo, A; Zibetti, M | 1 |
| Andreotti, F; Brouwer, MA; Bukowski, P; Conte, M; Gajda, J; Gajda, R; Jasiewicz, M; Kubica, A; Kubica, J; La Torre, G; Lackowski, P; Michalski, P; Navarese, EP; Nowicka, M; Omyła, M; Orsini, N; Piasecki, M; Pietrzykowski, Ł; Pinkas, J; Podhajski, P; Radziwanowski, A; Szymański, P; Urbanowicz, I | 1 |
| McConvey, V; Miyasaki, J; Ray Chaudhuri, K; Rukavina, K | 1 |
| Azulay, JP; Carron, R; Eusebio, A; Grimaldi, S; Regis, JM; Velly, L; Witjas, T | 1 |
| Chan, P; Chen, J; Chi, CL; Han, C; Li, F; Ma, JH; Zhang, X; Zhao, Y; Zhao, ZZ | 1 |
| Tipton, PW; Wszolek, ZK | 1 |
| Antonini, A; Chaudhuri, KR; Leta, V; Teo, J | 1 |
| Awad, N; Roy, D; Song, J; Zamudio, P | 1 |
| Artusi, CA; Bozzali, M; Ledda, C; Lopiano, L; Montanaro, E; Rizzone, MG; Romagnolo, A; Zibetti, M | 1 |
| Katunina, EA | 1 |
| Barone, P; Buonomo, AR; Erro, R; Pellecchia, MT | 1 |
3 review(s) available for levodopa and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
SARS-CoV-2 vaccination, Parkinson's disease, and other movement disorders: case series and short literature review.
Topics: Carbidopa; COVID-19; COVID-19 Vaccines; Deep Brain Stimulation; Drug Combinations; Humans; Immunization, Secondary; Levodopa; Male; Middle Aged; Movement Disorders; Parkinson Disease; Treatment Outcome; Vaccination | 2022 |
Deep Brain Stimulation-Withdrawal Syndrome in Parkinson's Disease: Risk Factors and Pathophysiological Hypotheses of a Life-Threatening Emergency.
Topics: COVID-19; Deep Brain Stimulation; Humans; Levodopa; Pandemics; Parkinson Disease; Treatment Outcome | 2023 |
COVID-19 and Parkinson's Disease: What Do We Know So Far?
Topics: Antiparkinson Agents; Case-Control Studies; COVID-19; COVID-19 Drug Treatment; Humans; Levodopa; Parkinson Disease; Vitamin D | 2021 |
1 trial(s) available for levodopa and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Ion channel inhibition with amiodarone or verapamil in symptomatic hospitalized nonintensive-care COVID-19 patients: The ReCOVery-SIRIO randomized trial.
Topics: Amiodarone; C-Reactive Protein; Carbidopa; COVID-19; Drug Combinations; Humans; Ion Channels; Levodopa; SARS-CoV-2; Verapamil | 2022 |
9 other study(ies) available for levodopa and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Impact of COVID-19 pandemic on acute heart failure admissions and mortality: a multicentre study (COV-HF-SIRIO 6 study).
Topics: Acute Disease; Carbidopa; COVID-19; Drug Combinations; Heart Failure; Humans; Levodopa; Pandemics; Retrospective Studies; SARS-CoV-2 | 2022 |
COVID-19 infection presented as severe dyskinesia in a patient with Parkinson's disease: a case with daily video recording.
Topics: Antiparkinson Agents; COVID-19; Dyskinesias; Humans; Levodopa; Parkinson Disease; Video Recording | 2022 |
Parkinson's disease and Covid-19: Is there an impact of ethnicity and the need for palliative care.
Topics: COVID-19; Disabled Persons; Ethnicity; Humans; Levodopa; Motor Disorders; Palliative Care; Pandemics; Parkinson Disease; Quality of Life | 2022 |
A large survey on COVID-19 vaccination in patients with Parkinson's disease and healthy population.
Topics: Antiparkinson Agents; COVID-19; COVID-19 Vaccines; Humans; Levodopa; Parkinson Disease; Vaccination | 2023 |
What can Parkinson's disease teach us about COVID-19?
Topics: Antiparkinson Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Levodopa; Pandemics; Parkinson Disease; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Outcome of Parkinson's Disease Patients Affected by COVID-19.
Topics: Aged; Aged, 80 and over; Betacoronavirus; Carbidopa; Coronavirus Infections; COVID-19; Female; Humans; Levodopa; Male; Pandemics; Parkinson Disease; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome | 2020 |
Treatment of unexplained coma and hypokinetic-rigid syndrome in a patient with COVID-19.
Topics: Blood Coagulation; Brain Diseases; Carbidopa; Central Nervous System Stimulants; Cognitive Dysfunction; COVID-19; Critical Care; Drug Combinations; Humans; Hypokinesia; Ischemic Stroke; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Modafinil; Rehabilitation; Respiration, Artificial; SARS-CoV-2; Severity of Illness Index; Treatment Outcome; Ventilator Weaning | 2021 |
[Amantadine in the treatment of Parkinson's disease. New opportunities in the context of COVID-19].
Topics: Amantadine; Antiparkinson Agents; COVID-19; Humans; Levodopa; Parkinson Disease; SARS-CoV-2 | 2021 |
Severe Dyskinesia After Administration of SARS-CoV2 mRNA Vaccine in Parkinson's Disease.
Topics: COVID-19; Dyskinesia, Drug-Induced; Humans; Levodopa; Parkinson Disease; RNA, Messenger; RNA, Viral; SARS-CoV-2; Vaccines | 2021 |